Cargando…

Interferon antagonists encoded by SARS-CoV-2 at a glance

The innate immune system is a powerful barrier against invading pathogens. Interferons (IFNs) are a major part of the cytokine-mediated anti-viral innate immune response. After recognition of a pathogen by immune sensors, signaling cascades are activated that culminate in the release of IFNs. These...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung-Hyun, Koepke, Lennart, Kirchhoff, Frank, Sparrer, Konstantin M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976456/ https://www.ncbi.nlm.nih.gov/pubmed/35366686 http://dx.doi.org/10.1007/s00430-022-00734-9

Ejemplares similares

Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins
por: Hirschenberger, Maximilian, et al.
Publicado: (2021)

Manipulation of autophagy by SARS-CoV-2 proteins
por: Koepke, Lennart, et al.
Publicado: (2021)

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
por: Jung, Christoph, et al.
Publicado: (2022)

Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
por: Nchioua, Rayhane, et al.
Publicado: (2023)

SARS-CoV-2 Nsp1: Ein kleines Protein blockiert die Immunantwort
por: Sparrer, Konstantin, et al.
Publicado: (2021)

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
por: Nchioua, Rayhane, et al.
Publicado: (2022)

Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
por: Hayn, Manuel, et al.
Publicado: (2021)

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
por: Thoms, Matthias, et al.
Publicado: (2020)

Near-Native Visualization of SARS-CoV-2 Induced Membrane Remodeling and Virion Morphogenesis
por: Bergner, Tim, et al.
Publicado: (2022)

Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
por: Pastorio, Chiara, et al.
Publicado: (2022)

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization
por: Pastorio, Chiara, et al.
Publicado: (2023)

SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
por: Li, Aixin, et al.
Publicado: (2021)

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal Organoids
por: Krüger, Jana, et al.
Publicado: (2020)

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
por: Nchioua, Rayhane, et al.
Publicado: (2022)

Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance
por: Dholariya, Sagar, et al.
Publicado: (2021)

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor
por: Zech, Fabian, et al.
Publicado: (2023)

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
por: Prelli Bozzo, Caterina, et al.
Publicado: (2021)

The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance
por: Islam, Md. Rezaul, et al.
Publicado: (2022)

HIV-1 infection activates endogenous retroviral promoters regulating antiviral gene expression
por: Srinivasachar Badarinarayan, Smitha, et al.
Publicado: (2020)

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans
por: Nchioua, Rayhane, et al.
Publicado: (2020)

SARS-CoV-2 and interferon blockade
por: Diamond, Betty, et al.
Publicado: (2020)

An improved method for high-throughput quantification of autophagy in mammalian cells
por: Koepke, Lennart, et al.
Publicado: (2020)

HIV protease: late action to prevent immune detection
por: Sparrer, Konstantin M. J., et al.
Publicado: (2021)

Cap snatch prevention: a novel approach to tackle influenza viruses
por: Sparrer, Konstantin M. J., et al.
Publicado: (2023)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
por: Hoang, Timothy N., et al.
Publicado: (2022)

The early interferon catches the SARS-CoV-2
por: Decker, Thomas
Publicado: (2021)

Clash of the titans: interferons and SARS-CoV-2
por: Jouvenet, Nolwenn, et al.
Publicado: (2021)

Identification of encoding proteins related to SARS-CoV
por: Mei, Hu, et al.
Publicado: (2004)

Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides
por: Millul, Jacopo, et al.
Publicado: (2023)

Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2—An in silico glance
por: Marchan, Jose
Publicado: (2020)

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
por: Yuen, Chun-Kit, et al.
Publicado: (2020)

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
por: Hung, Hui-Chen, et al.
Publicado: (2020)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

Interferon Resistance of Emerging SARS-CoV-2 Variants
por: Guo, Kejun, et al.
Publicado: (2021)

Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
por: Jhuti, Diya, et al.
Publicado: (2022)

Interferon resistance of emerging SARS-CoV-2 variants
por: Guo, Kejun, et al.
Publicado: (2022)

Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
por: Oleinik, L. A., et al.
Publicado: (2023)

Mechanisms of impairment of interferon production by SARS-CoV-2
por: Hoang, Huy-Dung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a05blkqkt3jafl25cdaj5iqf1i